Free Express Shipping on Orders $450+ | Peptide of the Week: Tirzepatide - 10% Off This Week
PT-141, also known in the scientific literature as Bremelanotide, remains one of the most closely studied melanocortin-system peptides in Canadian laboratory research because it acts through central melanocortin pathways rather than through PDE5-style vascular mechanisms. This guide explains what PT-141 is, why researchers continue to study it in 2026, and what purity, documentation, shipping, and research-only standards matter most when sourcing it in Canada.
PT-141 is a synthetic melanocortin receptor peptide studied for direct central nervous system signaling through melanocortin pathways, especially MC4R-focused research, with additional interest across the broader melanocortin receptor family. It is valued in laboratory settings because it operates through neurochemical receptor signaling rather than through nitric-oxide or vascular PDE5-type mechanisms.
PT-141 remains important because it gives researchers a peptide model that acts directly through melanocortin receptor signaling instead of acting through peripheral vascular pathways. That difference makes it especially useful in receptor-mapping, central signaling, and behavioral-neurobiology research.
PT-141 is a melanocortin peptide used by researchers to study how the brain and central signaling systems respond to receptor activation. It is fundamentally different from PDE5-type compounds because it is studied for central receptor effects rather than blood-flow mechanisms.
In 2026, PT-141 continues to stand out because it is one of the clearest peptide examples of centrally active melanocortin-pathway research.
PT-141 is a synthetic melanocortin peptide with the sequence Ac-Nle-c[Asp-His-DNal(2’)-Arg-Trp-Lys]-OH and CAS number 189691-06-3. It is studied as a receptor-active peptide within the melanocortin system, with particular emphasis on central melanocortin signaling.
PT-141 is studied because it engages melanocortin receptor pathways directly, with strong research emphasis on central receptor activation and neural-cascade signaling.
| Pathway | What Researchers Study | Why It Matters |
|---|---|---|
| MC4R activation | Central melanocortin signaling, behavioral modulation, and neural-cascade activation | MC4R is a major focus because of its strong central nervous system relevance. |
| Broader melanocortin receptor-family interaction | Receptor selectivity across melanocortin pathways | Helps researchers map where PT-141 sits within the wider melanocortin framework. |
| Direct central pathway engagement | Neurochemical and behavioral pathway activation | Distinguishes PT-141 from peripheral vascular research compounds. |
MC4R remains one of the main receptor systems associated with PT-141 research because it links central melanocortin activity to broader behavioral and neurological pathways.
That receptor-level clarity is one reason PT-141 continues to appear in central nervous system and melanocortin mapping studies.
PT-141 and Kisspeptin are sometimes compared because both appear in central-signaling research, but the receptor systems they target are different.
| Feature | PT-141 | Kisspeptin |
|---|---|---|
| Primary receptor focus | Melanocortin system, especially MC4R-focused research | GPR54 / Kiss1R |
| Research category | Melanocortin signaling | Hypothalamic and reproductive-signaling research |
| CNS involvement | Strong central receptor signaling emphasis | Moderate to strong hypothalamic pathway emphasis |
| Pathway logic | Direct receptor agonist framework | GnRH-linked modulation framework |
Because PT-141 is commonly used in receptor-level signaling research, Canadian laboratories generally expect strong analytical documentation and batch-level transparency.
| Standard | Why It Matters |
|---|---|
| ≥99% purity | Supports cleaner receptor-binding and signaling studies. |
| Batch-specific COA | Improves traceability and repeatability between lots. |
| HPLC chromatogram | Provides analytical support for purity claims. |
| Mass spectrometry confirmation | Supports molecular identity verification. |
| Clear labeling and batch tracking | Reduces confusion and protects workflow integrity. |
Domestic Canadian sourcing remains important because reduced transit time and more predictable handling help preserve research-material stability.
PT-141 must remain within a strict research-use-only framework in Canada.
Canadian researchers generally avoid suppliers that weaken trust around documentation, labeling, shipping origin, or research-use-only discipline.
Documentation and transparency remain essential quality signals in this category.
These pages extend the broader melanocortin, neurochemical, and research-quality context around PT-141.
These answers cover the most common PT-141 research and sourcing questions in 2026.
PT-141 is studied as a centrally acting melanocortin peptide, while PDE5-style compounds are associated with peripheral vascular pathways. Researchers treat these as fundamentally different mechanisms.
PT-141 appears in broader central-signaling and behavioral-response research without being limited to a single sex-specific model, which is one reason it remains relevant in melanocortin-system studies.
Researchers may compare PT-141 against other central-signaling or receptor-targeted compounds in controlled laboratory designs, but any combination framework should remain within strict research-use-only protocols.
Researchers generally keep lyophilized PT-141 under controlled low-temperature storage conditions consistent with standard peptide-handling protocols and supplier guidance, while avoiding repeated freeze-thaw cycles.
Luxara Labs emphasizes ≥99% purity expectations, batch-specific COAs, mass-spectrometry identity confirmation, transparent documentation pages, and strong domestic fulfillment standards so researchers can evaluate the quality framework more clearly.
These references support the melanocortin, central-signaling, and receptor-selectivity context discussed on this page.
Join our list and get an instant 10% discount code — valid for first-time buyers.